Patients with congenital adrenal hyperplasia (CAH) receiving glucocorticoid therapy showed reduced bone mineral density (BMD), with young adult male patients particularly affected and experiencing ...

CRENESSITY is available in capsule and oral solution forms and is prescribed alongside glucocorticoids to control androgen levels in adults and children aged four and older with classic CAH.